Stock- Based Awards and Stock-Based Employee Compensation Expense | 3. Stock- Based Awards and Stock-Based Employee Compensation Expense Our stock-based awards include (i) stock options, (ii) restricted stock awards, some of which are subject to time-based vesting (“Restricted Stock”) and some of which are subject to performance-based vesting (“Performance Stock”), and (iii) restricted stock units, some of which are subject to time-based vesting (“RSUs”) and some of which are subject to performance-based vesting (“Performance RSUs”). As of June 30, 2017, the Company had 1,075,486 stock options outstanding, 1,157,303 non-vested Restricted Stock awards; 193,110 non-vested Performance Stock awards; 129,420 non-vested RSUs; 60,663 non-vested Performance RSUs and 1,174,894 shares of common stock available for grant. Stock Option Activity The following is a summary of all stock option transactions during the three months ended June 30, 2017: Options Weighted Average Exercise Price Weighted Average Remaining Contractual Term (Yrs) Outstanding at March 31, 2017 1,902,521 $ 3.82 Granted at market price — — Cancelled or expired — — Exercised (827,035 ) 4.63 Outstanding at June 30, 2017 1,075,486 $ 3.19 5.63 Options exercisable at June 30, 2017 833,672 $ 3.00 4.69 At June 30, 2017, all 1,075,486 stock options outstanding and all 833,672 stock options exercisable had an exercise price lower than the market price of the Company’s common stock on that date. The aggregate intrinsic value of these stock options were $2.7 million and $2.2 million, respectively. The Company did not record an excess tax benefit for the three and six month periods ended June 30, 2017, related to the exercise of stock options. The Company did not record an excess tax benefit in the three month period ended June 30, 2016, but did record a $2 thousand excess tax benefit for the six month period ended June 30, 2016, related to the exercise of 19,812 stock options. Restricted Stock Activity The following is a summary of Restricted Stock activity during the three months ended June 30, 2017: Restricted Shares Weighted Average Fair Value Non-vested restricted stock at March 31, 2017 1,140,125 $ 4.52 Granted at market price 50,000 5.46 Vested (32,822 ) 3.87 Cancelled — — Non-vested restricted stock at June 30, 2017 1,157,303 $ 4.57 The Company did not record an excess tax benefit for the three and six month periods ended June 30, 2017, related to Restricted Stock awards that vested. The Company did not record an excess tax benefit for the three month period ended June 30, 2016, but did record a $32 thousand excess tax benefit for the six month period ended June 30, 2016, related to 168,750 Restricted Stock awards that vested. Restricted Stock Unit Activity The following is a summary of all RSU activity during the three months ended June 30, 2017: Restricted Stock Units Weighted Average Fair Value Non-vested restricted stock units at March 31, 2017 129,420 $ 4.39 Granted at market price — — Vested — — Cancelled — — Non-vested restricted stock units at June 30, 2017 129,420 $ 4.39 The Company did not record an excess tax benefit for the three and six month periods ended June 30, 2017, related to RSUs that vested. The Company did not record an excess tax benefit for the three month period ended June 30, 2016, but did record a $5 thousand excess tax benefit for the six month period ended June 30, 2016, related to 133,664 RSUs that vested. Performance RSU Activity The following is a summary of all Performance RSU activity during the three months ended June 30, 2017: Performance RSUs Weighted Average Fair Value Non-vested performance RSUs at March 31, 2017 60,663 $ 4.02 Granted at market price — — Vested — — Forfeited — — Non-vested performance RSUs at June 30, 2017 60,663 $ 4.02 The Company did not record an excess tax benefit for the three and six month periods ended June 30, 2017. The Company did not record an excess tax benefit for the three month period ended June 30, 2016, but did record a $12 thousand excess tax benefit for the six month period ended June 30, 2016, related to 77,428 Performance RSUs that vested. Performance Stock Activity The following is a summary of all Performance Stock activity during the three months ended June 30, 2017: Performance Stock Weighted Average Fair Value Non-vested performance stock at March 31, 2017 193,110 $ 4.39 Granted at market price — — Vested — — Forfeited — — Non-vested performance stock at June 30, 2017 193,110 $ 4.39 The Company did not record an excess tax benefit for each of the three and six month periods ended June 30, 2017, and 2016. The weighted average grant-date fair value of awards of Restricted Stock, RSUs, Performance RSUs and Performance Stock is based on the quoted market price of the Company’s common stock on the date of grant. Stock-Based Compensation Expense For the three and six month periods ended June 30, 2017, the total stock-based employee compensation expense resulting from stock options, Restricted Stock, RSUs, Performance RSUs and Performance Stock was recorded to the following line items of the Company’s condensed consolidated statements of income: (In thousands) Three Months Ended June 30, 2017 Six Months Ended June 30, 2017 Cost of revenues $ 77 $ 148 Research and development 97 177 Selling, general and administrative 515 954 Stock-based compensation expense $ 689 $ 1,279 A deferred tax asset totaling $374 thousand and $303 thousand, resulting from stock-based compensation expense associated with awards relating to the Company’s U.S. operations, was recorded for the six month periods ended June 30, 2017 and 2016, respectively. As of June 30, 2017, there was $6.1 million of total unrecognized stock-based compensation expense related to non-vested stock-based compensation awards granted under the incentive plans. This expense is expected to be recognized over a weighted average period of 1.70 years. For additional information regarding the Company’s Equity Awards and Stock-based Employee Compensation, see Note 3 to the consolidated financial statements contained in our Annual Report on Form 10-K for the fiscal year ended December 31, 2016. |